Hyperinduction of cyclooxygenase-2-mediated proinflammatory cascade: a mechanism for the pathogenesis of avian influenza H5N1 infection.

  title={Hyperinduction of cyclooxygenase-2-mediated proinflammatory cascade: a mechanism for the pathogenesis of avian influenza H5N1 infection.},
  author={Suki Man-Yan Lee and Chung-yan. Cheung and John M. Nicholls and Kenrie P Y Hui and Connie Y. H. Leung and Mongkol Uiprasertkul and George L. Tipoe and Yu-Lung Lau and Leo L. M. Poon and Nancy Y. Ip and Yi Guan and J. S. Malik Peiris},
  journal={The Journal of infectious diseases},
  volume={198 4},
The mechanism for the pathogenesis of H5N1 infection in humans remains unclear. This study reveals that cyclooxygenase-2 (COX-2) was strongly induced in H5N1-infected macrophages in vitro and in epithelial cells of lung tissue samples obtained during autopsy of patients who died of H5N1 disease. Novel findings demonstrated that COX-2, along with tumor necrosis factor alpha and other proinflammatory cytokines were hyperinduced in epithelial cells by secretory factors from H5N1-infected… 

Figures from this paper

H5N1 influenza virus-induced mediators upregulate RIG-I in uninfected cells by paracrine effects contributing to amplified cytokine cascades.

It is shown that the innate sensing receptor RIG-I is involved in interferon regulatory factor 3 (IRF3), NF-κB nuclear translocation, p38 activation, and the subsequentInterferon (IFN) β, IFN-λ1, and tumor necrosis factor α induction during H5N1 infection.

Influenza A viruses suppress cyclooxygenase-2 expression by affecting its mRNA stability

A novel IAV-regulated cellular mechanism, contributing to the repression of host defence and therefore facilitating viral replication is indicated, suggesting a tight regulation of COX-2 by IAV.

Induction of Proinflammatory Cytokines in Primary Human Macrophages by Influenza A Virus (H5N1) Is Selectively Regulated by IFN Regulatory Factor 3 and p38 MAPK1

It is concluded that IRF3 and p38 kinase separately and predominantly contribute to H5N1-mediated induction of IFn-β, IFN-λ1, and MCP-1 but only partly control TNF-α induction.

Prostaglandin E2 Induction during Mouse Adenovirus Type 1 Respiratory Infection Regulates Inflammatory Mediator Generation but Does Not Affect Viral Pathogenesis

While P GE2 promotes the expression of a variety of cytokines in response to acute MAV-1 infection, PGE2 synthesis does not appear to be essential for generating pulmonary immunity.

Pro-inflammatory Effects of Influenza Type A Virus PB1-F2 Protein-derived Peptide in Lipopolysaccharide-treated Macrophages.

It is suggested that PB1-F2 peptide may partly exert its enhancing role in viral pathogenicity through the induction of inflammatory mediators in macrophages and targeting it would be helpful in the reduction of viral infection complications.

Systems-Level Comparison of Host-Responses Elicited by Avian H5N1 and Seasonal H1N1 Influenza Viruses in Primary Human Macrophages

A network-based analysis suggests that the synergy between IFN-β and TNF-α results in an enhanced and sustained IFN and pro-inflammatory cytokine response at the early stage of viral infection that may contribute to the viral pathogenesis and this is of relevance to the design of novel therapeutic strategies for H5N1 induced respiratory disease.

High Expression of IL-36γ in Influenza Patients Regulates Interferon Signaling Pathway and Causes Programmed Cell Death During Influenza Virus Infection

It is demonstrated IL-36γ is a critical host immune factor in response to IAV infection and has potential activity in the regulation of the interferon signaling pathway and was involved in different types of programmed cell death in human airway epithelial cells as well.

Immunomodulatory therapy for severe influenza

This review discusses the limitations of current antiviral drug treatment strategies, describes the influenza viral and host pathogenicity determinants, and presents the evidence supporting the use of immunomodulatory therapy to target the host inflammatory response as a means to improve clinical outcome in severe influenza.

Targeting eicosanoid pathways in the development of novel anti-influenza drugs

An overview of a number of studies investigating the function of NSAIDs in the host response to IAV infection and the potential beneficial action of microsomal prostaglandin E synthase-1 inhibitory compounds in the treatment of IAV infections and potentially other RNA viruses is provided.



Proinflammatory cytokine responses induced by influenza A (H5N1) viruses in primary human alveolar and bronchial epithelial cells

The H5n1/97 and H5N1/04 subtype influenza A viruses are more potent inducers of proinflammatory cytokines and chemokines in primary human respiratory epithelial cells than subtype H1N1 virus, and it is suggested that this hyper-induction of cytokines may be relevant to the pathogenesis of human H4N1 disease.

Contrasting Effects of Cyclooxygenase-1 (COX-1) and COX-2 Deficiency on the Host Response to Influenza A Viral Infection1

COX-1 deficiency is detrimental whereas COX-2 deficiency is beneficial to the host during influenza viral infection, and these differences are associated with altered production of prostaglandins and leukotrienes following infection.

Inhibition of the cytokine response does not protect against lethal H5N1 influenza infection

It is demonstrated that mice deficient in the hallmark inflammatory cytokines TNF-α, IL-6, or CC chemokine ligand 2 succumb to infection with A/Vietnam/1203/04 (H5N1) virus, as do wild-type mice treated with glucocorticoids for suppression of cytokines.

Cyclooxygenase-2 biology.

  • J. Clària
  • Biology, Medicine
    Current pharmaceutical design
  • 2003
Novel compounds that are selective for this isozyme, the so-called selective COX-2 inhibitors or COXIBs, which retain anti-inflammatory activity but minimize the risk of gastrointestinal toxicity and bleeding, have been developed.

Highly Pathogenic Avian Influenza H5N1 Viruses Elicit an Attenuated Type I Interferon Response in Polarized Human Bronchial Epithelial Cells

The data suggest that the H5N1 viruses tested, especially the virus with the high-pathogenicity phenotype, possess greater capability to attenuate the type I IFN response than the human H3N2 virus.

Eicosanoids in inflammation: biosynthesis, pharmacology, and therapeutic frontiers.

Mechanisms for the production of pro-inflammatory eicosanoid mediators contributing to inflammation are described and promising options for the prevention of inflammatory mediator formation and the therapeutic inhibition of pain and inflammation are summarized.

Pathology of fatal human infection associated with avian influenza A H5N1 virus

It is postulated that in fatal human infections with this avian subtype, initial virus replication in the respiratory tract triggers hypercytokinemia complicated by the reactive hemophagocytic syndrome.

Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia

The observations indicate that high viral load, and the resulting intense inflammatory responses, are central to influenza H5N1 pathogenesis and the focus of clinical management should be on preventing this intense cytokine response, by early diagnosis and effective antiviral treatment.

Influenza A H5N1 Replication Sites in Humans

In contrast to disseminated infection documented in other mammals and birds, H5N1 viral replication in humans may be restricted to the lung and intestine, and the major site of H5E viruses replication in the lung is the pneumocyte.